Skip to main content

Aldeyra Therapeutics, Inc.

ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001341235

No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.

Politicians who traded ALDX

No member of Congress has reported a trade in Aldeyra Therapeutics, Inc. shares or options since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.